Comparing the vascular thromboembolic events following arteriovenous fistula in Chinese population with end-stage renal diseases receiving Clopidogrel versus Beraprost sodium therapy: a retrospective cohort study

Table 3 VTE risk ratio between groups

Variable	CL (n = 112)	BPS (n = 110)	P - value
Total VTE HR (95%CI)	6.98	3.42	0.001*
Total VTE HR (95%CI)	(3.17-18.61)	(1.46–8.53)
VTE HR (95%CI)
during 1st Mos	7.15	3.29	0.135*
during 1st Mos	(2.49-15.11)	(1.21–6.67)
during 2nd Mos	26.58	24.37	0.181*
during 2nd Mos	(8.53-89.17)	(7.64–101.72)
from 3rd Mos to data cut-off	19.36	14.15	0.214*
from 3rd Mos to data cut-off	(6.62-86.19)	(5.13–86.24)

CL clopidogrel, BPS beraprost sodium, VTE vascular thromboembolic event, HR hazard ratio, CI confidence interval, Mos month
*Statistically significant values

ISSN: 1471-2369